Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi: Skye Bioscience (SKYE)

Compliance with environmental standards in laboratories is driving growth, and EBITDA fluctuations on GURU.Markets reflect this trend, where the value of 0.00 expresses the metric level. Skye Bioscience, Inc. (SKYE) is developing a synthetic cannabinoid system to combat obesity. The global scaling of innovative formulas ensures high margins. This chart demonstrates real cash flow compared to historical data.

SKYE Bathi sadurunge mbayar bunga, pajak, lan amortisasi Skye Bioscience, Inc. (23.11.2025 - 12.11.2026)

Skye Bioscience, Inc. - rincian analitis lan metrik utama (SKYE)

- rega pasar lan target rega analis:

Rega saham Skye Bioscience Inc.|SKYE - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Skye Bioscience|SKYE - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Akuntansi saben Saham Skye Bioscience|SKYE - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku skyebioscience.com|SKYE - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Total Utang marang Modal Skye Bioscience, Inc.|SKYE - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal skyebioscience.com|SKYE - Gunggung utang perusahaan|Utang-utang marang nilai buku Skye Bioscience|SKYE - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Skye Bioscience|Likuiditas cepet skyebioscience.com

- data bathi lan kelipatan valuasi:

SKYE - Bathi resik|Prakiraan bathi perusahaan Skye Bioscience, Inc.|SKYE - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Skye Bioscience Inc.|SKYE - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Skye Bioscience|SKYE - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Skye Bioscience|SKYE - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan skyebioscience.com|SKYE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Skye Bioscience, Inc.

Ringkesan analitik perusahaan:Skye Bioscience, Inc.

This metric measures the amount of cash generated by the core business before deducting depreciation and interest, reflecting the actual efficiency of the operating cycle. Analyzing EBITDA history allows for an assessment of the risks of acquiring an asset at peak earnings, which is particularly critical for Skye Bioscience (SKYE) during the automation of molecule screening via robotic manipulators to accelerate the development of cannabinoid drugs.

Analisis pesaing Skye Bioscience, Inc.